Related Experiment Videos

Resistance of germfree rats to indomethacin-induced intestinal lesions

Prostaglandins
|August 1, 1977
PubMed

Insights

Microorganisms are essential for indomethacin to cause fatal intestinal lesions in rats. Germfree rats are resistant, but E. coli infection restores sensitivity, suggesting a role for gut bacteria in drug-induced injury.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Pharmacology

Background:

  • Indomethacin, a nonsteroidal anti-inflammatory drug, can induce intestinal lesions.
  • The role of the gut microbiota in the pathogenesis of drug-induced gastrointestinal injury is not fully understood.

Purpose of the Study:

  • To investigate the role of microorganisms in the development of indomethacin-induced intestinal lesions.
  • To explore the potential protective mechanisms of the intestinal mucosa against indomethacin toxicity.

Main Methods:

  • Oral administration of indomethacin to conventional and germfree rats.
  • Monocontamination of germfree rats with Escherichia coli (E. coli).
  • Assessment of intestinal lesion severity and peritonitis.

Main Results:

  • Conventional rats developed severe, often fatal, intestinal lesions and peritonitis after indomethacin administration.
  • Male germfree rats were resistant, while female germfree rats showed only mild lesions.
  • Monocontamination with E. coli rendered germfree rats sensitive to indomethacin, but lesions were less severe than in conventional rats.
  • Secondary bile acids, absent in germfree animals, may also be necessary for lesion development.

Conclusions:

  • Microorganisms are necessary for the development of indomethacin-induced intestinal lesions.
  • Prostaglandin deficiency induced by indomethacin may compromise mucosal resistance to microbial invasion.
  • Prostaglandins might exert a "cytoprotective" effect by preventing microbial and/or toxin translocation across the intestinal wall.

Related Concept Videos